Literature DB >> 9839284

Microalbuminuria in essential hypertension.

J L Rodicio1, C Campo, L M Ruilope.   

Abstract

Microalbuminuria is frequently seen in patients with established essential hypertension, and is a predictor of a higher risk for cardiovascular and probably renal dysfunction. The presence of microalbuminuria has been shown to correlate with the other cardiovascular risk factors commonly seen in hypertensive patients. This fact indicates that the detection of an increased urinary albumin excretion could probably be the best index of an increased global cardiovascular risk in a given patient. Blood pressure control is accompanied by a fall in the content of albumin in urine. Agents with the capacity to block the renin-angiotensin system have shown a capacity to decrease urinary albumin excretion, which is independent of their ability to lower blood pressure. Whether or not a decrease in urinary albumin excretion is accompanied by an improved renal and cardiovascular prognosis in hypertensive patients remains to be elucidated.

Entities:  

Mesh:

Year:  1998        PMID: 9839284     DOI: 10.1046/j.1523-1755.1998.06813.x

Source DB:  PubMed          Journal:  Kidney Int Suppl        ISSN: 0098-6577            Impact factor:   10.545


  10 in total

1.  Nighttime BP in Elderly Individuals with Prediabetes/Diabetes with and without CKD: The HEIJO-KYO Study.

Authors:  Kenji Obayashi; Keigo Saeki; Norio Kurumatani
Journal:  Clin J Am Soc Nephrol       Date:  2016-02-25       Impact factor: 8.237

Review 2.  A diagnostic approach for the child with hypertension.

Authors:  Natasa Marcun Varda; Alojz Gregoric
Journal:  Pediatr Nephrol       Date:  2005-02-19       Impact factor: 3.714

3.  Microalbuminuria in diabetes mellitus: Association with age, sex, weight, and creatinine clearance.

Authors:  N K Chowta; P Pant; M N Chowta
Journal:  Indian J Nephrol       Date:  2009-04

4.  A Study of Microalbuminuria (MAU) and Advanced Glycation End Products (AGEs) Levels in Diabetic and Hypertensive Subjects.

Authors:  S Gawandi; S Gangawane; A Chakrabarti; S Kedare; K Bantwal; V Wadhe; A Kulkarni; S Kulkarni; M G R Rajan
Journal:  Indian J Clin Biochem       Date:  2017-02-01

5.  Albuminuria in Hypertensive Patients: Where the Choice of Antihypertensive Medications Matters:: Commentary on "Several Conventional Risk Markers Suggesting Presence of Albuminuria Are Weak Among Rural Africans With Hypertension".

Authors:  Arya Mani
Journal:  J Clin Hypertens (Greenwich)       Date:  2015-08-26       Impact factor: 3.738

6.  A prospective comparison of four antihypertensive agents in daily clinical practice.

Authors:  C Campo; J Segura; M L Fernández; L Guerrero; H Christiansen; L M Ruilope
Journal:  J Clin Hypertens (Greenwich)       Date:  2001 May-Jun       Impact factor: 3.738

7.  Per- and polyfluoroalkyl substances and kidney function: Follow-up results from the Diabetes Prevention Program trial.

Authors:  Pi-I D Lin; Andres Cardenas; Russ Hauser; Diane R Gold; Ken P Kleinman; Marie-France Hivert; Antonia M Calafat; Thomas F Webster; Edward S Horton; Emily Oken
Journal:  Environ Int       Date:  2021-01-19       Impact factor: 9.621

8.  Association between Metabolic Syndrome and Microalbuminuria in Korean Adults.

Authors:  Hyun-Ok Lee; Hyun-Ju Bak; Jin-Young Shin; Yun-Mi Song
Journal:  Korean J Fam Med       Date:  2015-03-23

9.  An Observational Registry to Assess Urinary Albumin Evolution in Saudi Hypertensive Patients with the Current Treatment Local algorithm: Results of the RATIONAL Study.

Authors:  Mostafa Qaid Al Shamiri; Saeed M G Al-Ghamdi; Rafif M Farahat; Hosam Nasr El Desouki; Mohammed Saeed ElNazer; Hossam El Deen Moustafa Saleh; Ashraf Abdulghani Abo El Naga; Adil Mohammed Salih; Khedr Abdul Aal Mahmoud; Nasim Ahmad Ahmad
Journal:  Int J Nephrol Renovasc Dis       Date:  2020-04-23

10.  Cardiac, Macro-, and Micro-Circulatory Abnormalities in Association With Individual Metabolic Syndrome Component: The Northern Shanghai Study.

Authors:  Fang Zhao; Rong Yang; Rusitanmujiang Maimaitiaili; Jiamin Tang; Song Zhao; Jing Xiong; Jiadela Teliewubai; Chen Chi; Jacques Blacher; Jue Li; Yawei Xu; Yan Jiang; Yi Zhang; Weiming Li
Journal:  Front Cardiovasc Med       Date:  2021-07-09
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.